A multicenter, randomized, double-blind, placebo-controlled, phase 3 trial of olanzapine plus triple antiemetic regimen for the prevention of multiday highly emetogenic chemotherapy-induced nausea and vomiting (OFFER study)-Reference-Cited by-同舟云学术

A multicenter, randomized, double-blind, placebo-controlled, phase 3 trial of olanzapine plus triple antiemetic regimen for the prevention of multiday highly emetogenic chemotherapy-induced nausea and vomiting (OFFER study)

Published:2023-01 Issue: Volume:55 Page:101771
ISSN:2589-5370
Container-title:eClinicalMedicine
language:en
Short-container-title:eClinicalMedicine

Author:

Zhao Yuanyuan^ORCID,Yang Yunpeng,Gao Fangfang,Hu Changlu,Zhong Diansheng,Lu Miaozhen,Yuan Zhiping,Zhao Jianqing,Miao Jidong,Li Yan,Zhu Jie,Wang Chunbin,Han Jianjun,Zhao Yanqiu,Huang Yan,Zhang Li^ORCID

Publisher

Elsevier BV

Subject

General Medicine

Reference36 articles.

1. Randomized open-label phase II trial of 5-day aprepitant plus ondansetron compared to ondansetron alone in the prevention of chemotherapy-induced nausea-vomiting (CINV) in glioma patients receiving adjuvant temozolomide;Patel;Support Care Cancer,2020

2. Addition of 3-day aprepitant to ondansetron and dexamethasone for prophylaxis of chemotherapy-induced nausea and vomiting among patients with diffuse large B cell lymphoma receiving 5-day cisplatin-based chemotherapy;Abdel-Malek;J Egypt Natl Canc Inst,2017

3. Efficacy of ondansetron against emesis induced by a multiple-day cisplatin-based chemotherapy regimen for malignant lymphoma;Kamiya;Hematology,2021

4. Cisplatin given at three divided doses for three consecutive days in metastatic breast cancer: an alternative schedule for one full dose with comparable efficacy but less CINV and hypomagnesaemia;Zhang;Breast Cancer Res Treat,2020

5. Curing metastatic testicular cancer;Einhorn;Proc Natl Acad Sci U S A,2002

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research trends on chemotherapy induced nausea and vomiting: a bibliometric analysis;Frontiers in Pharmacology;2024-09-13

2. Olanzapine Plus Triple Antiemetic Therapy for the Prevention of Carboplatin-Induced Nausea and Vomiting: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial;Journal of Clinical Oncology;2024-08-10

3. Two doses of fosaprepitant included prophylactic treatment for the three-day cisplatin-based chemotherapy induced nausea and vomiting;Journal of Cancer Research and Clinical Oncology;2024-06-05

4. Pharmacokinetics, pharmacodynamics, safety, and tolerability of dopamine-receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting;Expert Opinion on Drug Metabolism & Toxicology;2024-06-02

5. Randomized Placebo-Controlled Trial of Topical Capsaicin for Delayed Chemotherapy-Induced Nausea and Vomiting;JCO Global Oncology;2024-06